Helicobacter pylori - Epidemiology

What is Helicobacter pylori?

Helicobacter pylori (H. pylori) is a type of bacteria that infects the stomach lining and is known to be a major cause of peptic ulcers, gastritis, and can be a risk factor for gastric cancer. It was first identified in 1982 by Australian scientists Barry Marshall and Robin Warren.

How is Helicobacter pylori Transmitted?

H. pylori is primarily transmitted via the fecal-oral route or the oral-oral route. Contaminated food, water, or utensils can facilitate the spread of the bacteria. Close person-to-person contact in crowded or unsanitary living conditions can also contribute to transmission.

What is the Global Prevalence of Helicobacter pylori?

The prevalence of H. pylori infection varies significantly by region and socio-economic status. It is estimated that about 50% of the world's population is infected with H. pylori. Higher infection rates are observed in developing countries compared to developed nations, primarily due to differences in hygiene practices and sanitation.

What are the Risk Factors for Infection?

Several risk factors are associated with H. pylori infection, including:

Living in crowded conditions
Lack of clean water
Poor sanitary practices
Low socio-economic status
Infection in childhood

What are the Clinical Manifestations?

Most people infected with H. pylori do not develop symptoms. However, when symptoms occur, they may include:

Abdominal pain
Nausea
Loss of appetite
Frequent burping
Bloating
Weight loss

Long-term infection can lead to more severe complications such as peptic ulcers and gastric cancer.

How is Helicobacter pylori Diagnosed?

Diagnosis of H. pylori infection can be made using several methods:

Urea breath test
Stool antigen test
Blood antibody test
Endoscopy with biopsy

What are the Treatment Options?

H. pylori infection is typically treated with a combination of antibiotics and acid-suppressing medications. The standard treatment regimen, known as triple therapy, includes:

Two antibiotics (such as clarithromycin and amoxicillin or metronidazole)
A proton pump inhibitor (such as omeprazole)

In some cases, a bismuth-containing medication may also be included, resulting in a quadruple therapy.

What are the Public Health Implications?

H. pylori infection has significant public health implications due to its association with gastric malignancies and peptic ulcer disease. Reducing the prevalence of infection involves improving sanitation, hygiene, and access to clean water. Screening and treatment programs in high-prevalence areas can also be beneficial.

Research and Future Directions

Ongoing research aims to better understand the pathogenesis of H. pylori, develop more effective treatment regimens, and explore potential vaccines. Public health strategies continue to focus on reducing transmission and managing complications associated with the infection.

Relevant Publications

Clinical, Pathological and Endoscopic Features of Neoplastic or Non-neoplastic Reddish Depressed Lesions after Helicobacter pylori Eradication.

Issue Release: 2024

Trichilia catigua against Helicobacter pylori: An in vitro, molecular and in silico approach.

Issue Release: 2024

Helicobacter Pylori infection in children with inflammatory bowel disease: a prospective multicenter study.

Issue Release: 2024

The endoscopic model for gastric carcinogenesis and Helicobacter pylori infection: a potential visual mind-map during gastroscopy examination.

Issue Release: 2024

Apigenin attenuates indomethacin-induced gastric ulcer in rats: emphasis on antioxidant, anti-inflammatory, anti-apoptotic, and TGF-β1 enhancing activities.

Issue Release: 2024

METTL3-mediated N-methyladenosine modification of STAT5A promotes gastric cancer progression by regulating KLF4.

Issue Release: 2024

Cross-sectional imaging of gastric cancer: pearls, pitfalls and lessons learned from multidisciplinary conference.

Issue Release: 2024

Therapeutic potential of Phycocyanin in gastrointestinal cancers and related disorders.

Issue Release: 2024

Burden of Stomach Cancer Incidence, Mortality, Disability-Adjusted Life Years, and Risk Factors in 204 Countries, 1990-2019: An Examination of Global Burden of Disease 2019.

Issue Release: 2024

Pharmacological insight of rutin as a potential candidate against peptic ulcer.

Issue Release: 2024

Engineered low-pathogenic Helicobacter pylori as orally tumor immunomodulators for the stimulation of systemic immune response.

Issue Release: 2024

A prominent role of LncRNA H19 in H. pylori CagA induced DNA damage response and cell malignancy.

Issue Release: 2024

Advanced Interpenetrating Polymer Networks for Innovative Gastroretentive Formulations Targeting Helicobacter pylori Gastric Colonization.

Issue Release: 2024

Real-world evidence of a novel tetravalent immunoglobulin Y effectiveness and safety in patients with the refractory Helicobacter pylori infection.

Issue Release: 2024

Clinical analysis of the effect of helicobacter pylori infection on immune function in children with peptic ulcer.

Issue Release: 2024

Detection of infection in children using rapid urease and histologic methods of diagnosis.

Issue Release: 2024

A Prototype of Graphene E-Nose for Exhaled Breath Detection and Label-Free Diagnosis of Helicobacter Pylori Infection.

Issue Release: 2024

Biochemical characterization of paralyzed flagellum proteins A (PflA) and B (PflB) from Helicobacter pylori flagellar motor.

Issue Release: 2024

Efficacy of Magnifying Endoscopy with Narrow-Band Imaging in the Diagnosis of Early Gastric Cancer and Gastric Intraepithelial Neoplasia.

Issue Release: 2024

Prediction of Protein-Protein Interactions Based on Integrating Deep Learning and Feature Fusion.

Issue Release: 2024

What is Ethnicity in Epidemiology?

How Can Anthropology Help in Outbreak Investigations?

How Do Cultural Beliefs Impact Mental Health?

What is the International Epidemiological Association?

How Does Investment Impact Disease Control?

How Can We Improve Immunization Programs?

What is Percutaneous Coronary Intervention (PCI)?

Who Benefits from Newborn Screening?

What is the Opt-Out Option?

What are the Future Directions for Injury Tracking?

Partnered Content Networks

Relevant Topics